Objective. A number of studies have indicated that rheumatoid arthritis (RA) is a less severe disease in Mediterranean countries than in Northern Europe. We investigated whether differences in the frequency of class II MHC antigens might contribute to this variation in disease severity.
Introduction
cult, it is possible that these differences may be geneticRheumatoid arthritis (RA) is a heterogeneous inflamally determined. matory disorder characterized by persistent inflammat-RA is a complex polygenic disease, environmental ory synovitis leading to joint destruction, and is and genetic factors contributing to both predisposition sometimes associated with systemic complications. and the clinical course, but the relative importance of However, disease severity varies widely, and several such factors in disease expression is unknown. The beststudies and anecdotal reports indicate that the clinical characterized genetic component that is functional in presentation varies in different parts of the world, being RA is the association of alleles of the major histocompatless severe in Mediterranean countries such as Greece ibility complex (MHC ), in particular the genes encoding HLA-DR molecules. The use of DNA sequence analysis [1] and Spain [2] and more severe among northern has shown that alleles associated with RA encode a conserved amino acid sequence in the third hypervari-the association with certain HLA-DR alleles is subject Statistical analysis to ethnic variation due to the different baseline frequenAllele frequencies were calculated by direct counting. cies of the alleles in the populations affected [5] . In HLA allele frequencies in RA patient groups and conCaucasian patients, RA is strongly associated with DR4, trols were compared using the x2 test. Odds ratios (OR) in particular with the HLA-DRB1*0401, *0404 and and 95% confidence intervals (CI ) were calculated as *0408 alleles [6, 7] . In Japanese, Chinese and Korean cross-product ratios of a 2 × 2 contingency table patients, the rheumatoid epitope is present in HLA-
] by the Woolf method as modi-DRB1*0405 [8] [9] [10] . In Greece, Spain, Italy and Israel, fied by Haldane [29] . the alleles HLA-DRB1 *0405, *0101, *0102 and *1001 have been found [11] [12] [13] [14] [15] [16] [17] and DRB1*1402 has been Results found in Yakima Indians [18] .
Genetic differences may determine differences in disSixty-eight early RA patients were studied in Bath and ease expression, and it has been suggested that not all 68 in Madrid. Control populations comprised 226 (Bath) the alleles encoding the shared epitope are equivalent in and 929 (Madrid) persons of the same type of backterms of their association with susceptibility to or the ground and living in the same area as the patients. severity of RA when present either as a single allele or
The distribution of healthy controls with 0, 1 and 2 when two alleles are present. Patients with more severe SE alleles is shown in Table 1 . In Madrid, 38% of control disease show increased frequency of alleles with the subjects carried one or two alleles with the conserved disease susceptibility cassette [13] , are more likely to HVR3 sequence, compared with 48% in Bath have the SE encoded by an HLA-DR4 allele than a non-(P = 0.0001). These values represent 390 SE alleles (42% DR4 allele [19] [20] [21] or have two of these alleles [6, 7, of the total number of alleles in Spanish controls) and 22]. However, this does not seem to be true in all ethnic 131 alleles (58% of British control alleles), respectively groups. Most African-American and Hispanic-American (P = 1 × 10−5). Clear differences were noted in SE patients with RA do not express the shared epitope and distribution between the two control populations disease severity is similar for patients with and without (P = 1 × 10−7) (Table 2 ), in particular the presence of the epitope, independent of the allele dose [23, 24] .
HLA-DRB1*04 alleles (17.3 vs 7.7%). The increased The present study was undertaken to investigate expression of HLA-DRB1*04 in Bath was due to marked class II MHC polymorphisms among RA patients from over-representation of HLA-DRB1*0401 and, to a lesser two early synovitis clinics, in Bath ( UK ) and Madrid extent, *0404. Most controls in the two cities carried (Spain). We show that the frequencies of the SE and of DR4-associated DQB1*03 alleles, but the only difference HLA-DRB1*04 alleles are increased in British patients.
found was that the DR4-DQ*0301 haplotype was much These genetic factors may be responsible for the differmore prevalent in Bath than in Madrid (46 vs 19%, ences in the clinical course and disease outcome of early P = 0.00007) ( Table 3 ). RA seen in the two centres. Table 4 shows the number of RA patients with SE alleles. As in control subjects, there were differences in Patients and methods resolution typing by PCR and sequence-specific oligonucleotides (PCR-SSO) [28] .
SE distribution between the two patient groups

Patients
Global x2 test: x = 76.12, P = 1 × 10−7. and genetic factors contributing both to its induction and to its clinical course. The best-characterized genetic (P = 0.04). More patients in Bath (72%) carried SE component that is functional in RA is the association alleles than in Madrid (51%), this difference being due of alleles of the MHC, in particular with genes encoding to the numbers expressing one SE allele (59 vs 39%).
HLA-DR molecules. All disease-associated haplotypes The distribution of SE alleles was different in rheumatoid share a specific polymorphism encoded by the HVR3 of patients in the two cities (P = 0.003) ( Table 5 ). In Bath, the HLA-DRB1 gene, suggesting that this common SE-bearing alleles accounted for 58 (42.6%) of the 136 sequence is involved in the pathogenesis of RA [4] . alleles present in the patients, the SE being mainly HLA may be a factor in the initiation of the disease as associated with HLA-DRB1*04 alleles (43/58, 74.1%), its prevalence is high or low depending on the frequency in particular with HLA-DRB1*0401. In Madrid the SE of DRB1 alleles carrying the SE in the control populawas present on 43 (31.6%) of the 136 alleles present, tion. The high prevalence of RA in Tlingit Indians may and was almost equally distributed between DRB1*04 be explained by the high population frequency of the (51.1%) and DRB1*01 (44.7%) alleles, the frequency of DRB1*1402 allele [30] , while in Nigerians the low HLA-DRB1*01 being 2-fold higher than in Bath (44. 7 prevalence of RA may be related to the low frequency vs 22.4%). The haplotype DR4-DQB1*0301 was more of alleles with the SE [31] . In Spain, the prevalence of frequent in British patients (60 vs 37%, P = 0.05) RA is around 0.4% [32] , while in Britain it has been ( Table 3) .
reported to be 0.8% [33] . This difference is similar to In both British and Spanish RA patients, SE alleles the observed frequency of the SE in the Madrid and were more prevalent than in their respective control Bath control populations. There is evidence that HLA populations (Bath, 42.6 vs 28.9%, P = 0.002; Madrid, alleles are associated more with the severity of the 31.6 vs 19.8%, P = 0.001). The risk of developing disease than with its initiation. A low frequency of the RA in carriers of SE alleles was similar in the two SE in newly diagnosed patients with RA attending an cities (Bath, OR = 1.83, 95% CI 1.23-2.78; Madrid, early arthritis clinic has been described, and only a very OR = 1.87, 95% CI 1.25-2.77), and was largely weak association of disease with the SE has been found in community-based studies [34, 35] . In the present The frequency of the SE seems to be higher in chronic associated with RA, reflecting the prevalence of these alleles in the control populations and suggesting that Global x2 test: x = 17.48, P = 0.003.
HLA-DRB1 genes play a more important role in the with protection against RA and that the RA-associated DRB1 alleles are merely permissive for the true disease UK than in Spain.
The presence and dosage of HLA-DRB1 alleles with susceptibility conferred by certain HLA-DQ alleles [42] . However, this has not been supported by others [43] , the SE is associated with more severe disease in most RA patients [37] , including those in Spain [38] . Several as the strongest association in RA patients is with DRB1 genes rather than DQB1. Patients with more severe authors have reported a hierarchy of disease susceptibility alleles, with a more pronounced association with disease, including those with Felty's syndrome, have a higher incidence of HLA-DR4-associated DQ7 HLA-DRB1*0401 and *0404 and a greater frequency of two of these alleles in patients with more severe disease (DQB1*0301) [20, 43, 44] , but in Caucasians HLA-DRB1*0401 is in strong linkage disequilibrium with [6, 7, 22] , while those with milder disease were more likely to be DRB1*01 [20, 39] . From the above data it DQB1*0301 [43] . This extremely strong linkage disequilibrium between DQB1 and DRB1 alleles makes it might be supposed that RA should be mild among populations in which the SE alleles encoding DR4 are difficult to determine their relative importance in predisposition to RA and the severity of the disease, but it is less prevalent and primarily consist of non-*0401 or *0404. Our data are consistent with this hypothesis, as possible that both loci are important. Follow-up studies of the patient cohorts in Bath and Madrid may help to RA has been shown to be a less severe disease in Spanish than British patients [2] . We have shown that RA in elucidate this problem. It is clear that the shared epitope does not explain Spain, from the very early stages, shows a lower prevalence of the SE, and when it is present it is encoded the entire genetic predisposition to RA and that susceptibility to and severity of RA are governed by a limited almost equally by DR1 and DR4 alleles. However, this is not true in all populations, as most African-American number of genes. It has been proposed that HLA accounts for only a third of the genetic susceptibility to and Hispanic-American patients with RA do not express the SE and disease severity seems to be independent of RA [45] and that other genes must collaborate, but probably not in the same way in different populations. its presence and dose [23, 24] .
In the present study, we found that DR4-associated To identify other RA susceptibility loci, genome scans using a variable number of microsatellites have been SE alleles were increased in both British and Spanish patient groups. DR1 alleles were similar to controls in carried out. In these studies, linkage to HLA was confirmed but was not restricted to the HLA-DR locus Bath, but appeared to be more prevalent in Madrid, although this failed to reach significance with the present [46, 47] . The tumour necrosis factor ( TNF ) gene is in linkage disequilibrium with certain HLA-DRB1*04 number of patients. These data reflect differences in the frequency of these alleles in the normal population and alleles [48] , and has been found to have an HLA-DRB1-independent role in predisposition to RA [49] and may probably also the lower influence in this study of another SE allele which has been described as increased in influence radiological progression [50] . In both British and Spanish patients, TNF polymorphisms have been Mediterranean countries [5] . MHC polymorphisms modify the peptide binding site and control the antigenic related to age at disease onset [51, 52] . Although the contribution of TNF polymorphisms to the initiation peptides presented to T cells. Given the different ethnic distribution of HLA-DR molecules, it is reasonable to and outcome of RA is not clear [53] , it is possible that they may act as a second MHC-linked influence which speculate that different peptides may be related to RA [40] , and disease-associated environmental factors may might be more important in some populations than in others. be different in the two countries.
It has been proposed that the inheritance of two SE In summary, a multitude of factors appears to influence the clinical course of RA, including different comalleles confers a much higher risk of RA [41] . In our study, this was true only in Spain, although the number binations of disease risk genes. We have shown in this study that class II MHC gene expression is different in of patients was low. In Spain, the relation between SE and disease was different, as shown by the lower freearly British and Spanish RA patients and may contribute to differences in disease progression and outcome. quency of the SE and its almost equal distribution between DR4 and DR1 alleles. Our data support the concept that the SE differs in its contribution to the
